Access to the 750 mcg Injection Teriparatide formulation in Australia is currently . Although it is registered for use for the management of osteoporosis, distribution of this specific injection are significantly controlled . Physicians could need to seek individual authorization from a appropriate pathway secure it for patient's patients . It's ne